The role of radiological surveillance in the conservative management of incidental small testicular masses: A systematic review.

Objective: The increasing use of scrotal ultrasonography (US) for non-cancerous indications has led to greater detection of incidental, small testicular masses. Operative intervention is currently the mainstay of treatment for all testicular tumours; however, despite the low malignant potential of small, incidental masses, little is known about conservative management using radiological surveillance. Methods: A systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted and studies meeting the inclusion criteria were reviewed for patient outcomes. Results: A total of 293 patients across six studies underwent radiological surveillance for an incidental small testicular mass. Infertility was the main indication for investigation and all studies used US as the surveillance modality. A total of 37 patients (12.6%) underwent surgical exploration during follow-up, with only 10 (3.4%) found to have malignant disease at histology. Conclusions: Radiological surveillance of incidental small testicular masses is safe when used for select patient groups due to the high probability of benign disease, although optimal patient selection criteria and a well-defined protocol are lacking. This approach could be considered in patients with incidental, impalpable testicular masses of ≤5 mm in diameter displaying no significant size increase or internal vascularity on US and with negative tumour markers, as the probability of malignancy in these patients is low.

Surgical Management of Youssef's Syndrome: A Case Report.

Youssef's syndrome has been first described in 1957 as an atypical presentation of a vesicouterine fistula after lower segment Cesarean section. It is characterized by a triad of cyclic hematuria, amenorrhea, and absence of urinary incontinence, which is usually found in other forms of genitourinary fistulas. We describe a case report of a woman who developed a delayed Youssef's syndrome 3 months after her third Cesarean section. She was initially post-operatively treated conservatively and successfully for a bladder leakage through the wound with a bladder catheter for 1 month, and 2 months later, she developed symptoms as described above. She was successfully treated with uterus-sparing surgical fistula repair. Youssef's syndrome is a rare and atypical presentation. Physicians may easily be misled and diagnosis delayed. We describe the diagnostic approach and review the literature as to therapeutic approaches.

Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases.

OBJECTIVES: To report our experience with the emerging technique of thulium laser enucleation of the prostate (ThuLEP) for the treatment for prostate hyperplasia. PATIENTS AND METHODS: Our inclusion criteria were an International Prostate Symptom Score (IPSS) of >15 and a quality-of-life (QoL) score of >3 in patients with confirmed bladder outflow obstruction, no longer responsive to medical therapy, with a significant post-void residual urine volume (PVR; >100 mL), with or without recurrent urinary tract infection and/or acute urinary retention. Patients with neurogenic bladder, urethral strictures, bladder stones, and previously failed transurethral prostate surgery were excluded. RESULTS: In all, 139 men were included in the study. The mean age was 67.8 years. The IPSS and QoL score improved by 17.6 and 2.6, respectively. The flow rate increased from a mean of 9.6 mL to 31.2 mL and the PVR decreased from a mean of 131 mL to 30 mL. On univariate and multivariate analyses, operating time was a predictive factor for haemoglobin drop during the operation. Heparin prophylaxis was the only risk factor identified for postoperative bleeding. Two patients (0.01%) required blood transfusion. One patient (0.007%) required re-intervention for bleeding control, and two patients developed urethral and bladder neck strictures (0.01%). CONCLUSION: ThuLEP is safe and reproducible. Whilst it significantly reduces intraoperative bleeding as compared to transurethral resection of the prostate, operating time and perioperative heparin prophylaxis may still lead to a Hb drop and constitute a risk factor for postoperative bleeding. Therefore, a potential risk of deep vein thrombosis requiring heparin prophylaxis should be carefully considered and balanced with the expected clinical benefit of the operation.

Acceptance of mixed scientific and clinical activities in a sub-speciality urology meeting.

Basic urolithiasis research into the causes for stone formation has been stagnating for a long time. Emergence of effective stone treatment modalities has shifted the public and clinicians' focus away from basic research towards symptomatic treatment solutions. This has occurred in spite of urolithiasis being a highly recurrent disease with an enormous socio-economic impact warranting a prophylactic and recurrence-preventing approach. An integrated, multidisciplinary translational platform has been developed in the form of urolithiasis meetings bringing together urologists, radiologists, nephrologists, basic scientists, dieticians and other stake holders interested in stone disease, for an exchange of knowledge, mutual education and understanding, and professional networking. Traditionally, such combined meetings are split into sessions addressing the specific interests of clinicians and scientists. At the recent Experts in Stone Disease Symposium we devised and implemented a program which mixed clinical and basic science activities throughout. We interviewed delegates between sessions regarding their acceptance of this novel concept using a standardized questionnaire. Sessions were well-attended, alleviating our initial anxiety that delegates would not appreciate a "no-choice" program. Of the 74 delegates who were interviewed, 60 (81%) were urologists, and 14 (19%) were non-urologists such as nephrologists, dieticians, and students. This is representative of the overall distribution of delegates at the conference. 71% felt that a closer co-operation and understanding between clinicians and scientists will ultimately benefit both groups, as well as patients; 95% found the mixed session approach beneficial, with half appreciating it as very good and innovative; 94% believed that they had derived useful learnings from the "other side"; 94% found that such mixed sessions are useful for their future work and understanding of the urolithiasis field as a whole; 94% agreed that mixed meetings of this type are useful in enhancing networking between the different stake holders in urolithiasis treatment and research. Finally, 85% would like to visit future mixed session meetings, and 89% would encourage their juniors to attend, too. Not only was a platform created to facilitate multidisciplinary exchange and networking, but delegates from several different backgrounds were encouraged to attend presentations in disciplines other than their own. The results of our survey confirm an overwhelmingly positive acceptance of this integrated multidisciplinary concept for stone meetings. As such, we are encouraged to continue with this concept in future conferences.

Quality of life after percutaneous nephrolithotomy for caliceal diverticulum and secluded lower-pole renal stones.

BACKGROUND AND PURPOSE: The treatment of caliceal diverticulum and deeply secluded lower-pole stones is challenging, and the indications are controversial. This study assessed the changes in the quality of life (QoL) of patients undergoing percutaneous nephrolithotomy (PCNL) for symptomatic caliceal diverticula and deep lower-pole calculi to determine whether there is a change in the "bother factor" in order to improve treatment strategies for this group of patients. PATIENTS AND METHODS: Twenty-two patients undergoing PCNL were evaluated prospectively using the SF36 QoL questionnaire before and 6 weeks after PCNL. The results before and after PCNL were compared individually and by group and analyzed statistically. A P value

Influence of body temperature on indinavir crystallization under loop of Henle conditions.

OBJECTIVES: Indinavir is a protease inhibitor used in the therapy of HIV-1+ patients. It causes indinavir stone formation. It has been shown to precipitate in the loop of Henle (LH) at plasma concentrations (conc[P]) of approximately 8 mg/L. Those experiments were performed at room temperature. Given the influence of temperature on crystallization in general, and solubility of indinavir in particular, we repeated the experiments under physiological (body) temperature conditions. METHODS: Test solutions contained indinavir concentrations of 100-750 mg/L at ionic strengths varying from 0 to 800 mM simulating conditions in the proximal tubule and the LH. Solutions were titrated with base (NaOH) to find the pH value where nucleation is initiated. Experiments were conducted at room temperature (20 degrees C) and repeated under constantly monitored (body) temperature (37 degrees C). RESULTS: Experiments at 20 degrees C confirmed our previous results. At 37 degrees C, the relationship between pH and indinavir concentration remained inversely proportional. Again, the LH was confirmed as the most likely localization of crystallization. However, at 37 degrees C precipitation occurred at a lower urinary concentration (100 versus 125 mg/L) and within a lower pH range (6.67-7.26 versus 7.23-7.44). This lower urinary concentration corresponds to a lower conc[P] [critical value (CV)] of 6.41 mg/L, as compared with 8.01 mg/L at 20 degrees C. CONCLUSIONS: The CV is even lower at 37 degrees C than previously assumed. Plasma peak concentration above the CV of 6.4 mg/L will induce crystallization in the LH and should be avoided.

The (soon forgotten) art of open stone surgery: to train or not to train?

To date, open stone surgery is now performed in a very limited number of selected cases. A review of our own cases revealed that open surgery constituted 1% of all procedures. These procedures were mostly ablative, or operations to deal with complications of failed minimally invasive therapies. Given two continuing trends towards sub-specialisation in urology on the one hand, and minimally invasive therapy on the other, the question arises whether and how sub-specialised stone surgeons should and can learn open stone surgery. Is it merely a lost art not to be bothered with, or is it something worthwhile preserving? This article discusses the pros and cons of the argument and suggests centralisation of complex stone cases as a possible way out of the dilemma.

A new SWL titanium stent (Zebra Stent): resistance to shockwave exposure.

BACKGROUND AND PURPOSE: Recently, a new-concept lumen-less Teflon-coated double-J wire stent (Zebra stent) has been introduced to facilitate residual stone clearance, in particular after SWL. Its metal core expresses highly mismatched acoustic impedance. It was the aim of this study to exclude damage to the stent through shockwaves. Also, its Teflon coating should to some degree prevent encrustation, and stents removed from stone formers were examined for encrustation. MATERIALS AND METHODS: Series of 2000 shockwaves of an average and a maximum energy were applied to defined areas of Zebra stents in a waterbath on a Siemens Multiline Lithotriptor. Stents were then examined for core and sheath damage by digital photography, scanning electron microscopy, and microradiography. In addition, two Zebra stents and one conventional double-J stent from two stone formers were assessed in the same way for damage and encrustation. RESULTS: There was no damage whatsoever to either of the stents. Whereas there was considerable encrustation on the conventional double-J stent, there was none on the Zebra stents after 4 and 5 weeks in situ. CONCLUSIONS: Zebra stents resist shockwaves to a maximum number and energy sufficiently to be applied safely under SWL. Whether they resist encrustation to a higher degree in the short term than conventional stents remains to be established.

Transurethral ethanol ablation of prostate.

Transurethral ethanol ablation of the prostate (TEAP) has emerged among the treatment alternatives to transurethral resection of prostate as a promising minimally invasive therapy that can be performed on an outpatient basis with fewer complications. It was introduced approximately 5 years ago, and to date, 12-month results are encouraging. We herein review the procedure and outcomes of TEAP.

Ureterolithiasis after Cohen re-implantation--case report.

BACKGROUND: In the past decades, the widespread use of cross-trigonal ureteral reimplants for the treatment of children with vesicoureteral reflux has resulted in a large population of patients with transversely lying ureters. As this population gets older they will consequently be entering an age group at higher risk for stone and urothelial cancer formation. If ureteroscopy becomes necessary, the transverse position of the ureter makes ureteric access often impossible. CASE PRESENTATION: We present the case of a young man who not only suffered from urolithiasis due to hyperparathyroidism, but also further jeopardized his treatment by omitting the fact that as a child he underwent Cohen reimplantation of the right ureter. CONCLUSIONS: This case illustrates the particular difficulties the endoscopist may face in this group of patients. Patients with difficult ureteric access, abnormal anatomy, or those with known cross-trigonal ureteric reimplantations should be managed in a specialised endourology unit.